Q3 2023 · 13F-HR
Fairmount Funds Management LLCholdings as filed
Filed 2023-11-14 · accession 0001104659-23-118043
$831.2M
Reported value
20
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $163.6M | 19.7% | 2,341,238 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $112.7M | 13.6% | 2,451,819 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $94.1M | 11.3% | 5,929,592 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $62.6M | 7.54% | 2,941,176 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $44.4M | 5.34% | 1,881,345 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $43.0M | 5.17% | 2,474,561 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $41.2M | 4.95% | 83,747 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $34.7M | 4.17% | 3,558,975 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $33.7M | 4.06% | 1,142,473 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $29.1M | 3.50% | 2,131,369 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $28.8M | 3.46% | 750,000 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $27.1M | 3.26% | 1,221,904 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $26.4M | 3.17% | 1,928,503 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $21.0M | 2.53% | 1,369,623 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $19.2M | 2.31% | 1,393,329 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $14.2M | 1.71% | 1,901,397 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $11.3M | 1.35% | 5,163,287 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $10.3M | 1.23% | 2,040,000 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES SA | $9.2M | 1.11% | 6,781,150 | Common | SOLE |
| 00773J202 | SYRE | AEGLEA BIOTHERAPEUTICS INC | $4.6M | 0.56% | 378,421 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.